Search for: "Sanofi"
Results 121 - 140
of 1,196
Sort by Relevance
|
Sort by Date
11 May 2023, 10:12 am
By Chris Holman Sanofi-Aventis Deutschland GMBH v. [read post]
10 May 2023, 12:15 pm
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
10 May 2023, 12:15 pm
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
8 May 2023, 8:43 pm
Sanofi. [read post]
1 May 2023, 10:11 am
Sanofi case, argued in March 2023. [read post]
27 Apr 2023, 11:51 am
That result would likely lead to a non-infringement for Sanofi whose competing product is structurally different. [read post]
25 Apr 2023, 12:01 pm
Sanofi. [read post]
21 Apr 2023, 6:00 am
Broad Patent Claims Come Before the Supreme Court in Amgen v Sanofi. [read post]
19 Apr 2023, 6:34 am
Lawrence, Detroit Free Press) Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi (Fraiser Kansteiner, Fierce Pharma) An Abortion Drug Tests the Supreme Court (David Cole, The New York Review of Books) Senate Dems weighing a Clarence Thomas invite to future Supreme Court ethics hearing (Katherine Tully-Mcmanus & Burgess Everett, Politico) The post The morning read for Wednesday, April 19 appeared first on SCOTUSblog. [read post]
3 Apr 2023, 9:24 pm
Sanofi last week in an extended session with argument from the parties and the U.S. government. [read post]
29 Mar 2023, 9:58 pm
Sanofi, all three advocates (Jeff Lamken for Amgen, Paul Clement for Sanofi, and Colleen Sindzak for the United States) had reason to reference and discuss an amicus brief submitted on behalf of Nobel Prize-winning scientist Sir Gregory Winter and colleagues,* on the scientific questions raised in the case with regard to what is sufficient to satisfy the enablement requirement of 35 U.S.C. [read post]
29 Mar 2023, 12:09 pm
Arguing for Sanofi, Paul Clement told the justices that the patent covers “millions and millions of antibodies. [read post]
29 Mar 2023, 8:10 am
Sanofi case. [read post]
28 Mar 2023, 1:15 pm
Sanofi was long-awaited and closely watched by many in the patent community. [read post]
28 Mar 2023, 1:15 pm
Sanofi was long-awaited and closely watched by many in the patent community. [read post]
27 Mar 2023, 8:50 pm
Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure decisions, in this case enablement under 35 U.S.C. [read post]
27 Mar 2023, 8:27 pm
” Colleen Sinzdak argued on behalf of the US Gov’t as amicus and in support of Sanofi. [read post]
27 Mar 2023, 1:15 pm
Sanofi, a case that even Sanofi’s counsel agreed could effectively wipe out patents involving genus claims if the Court sides with Sanofi, or—as counsel for Sanofi and the Solicitor General’s Office suggested the Court could do—if it were to dismiss the case as improvidently granted. [read post]
27 Mar 2023, 1:15 pm
Sanofi, a case that even Sanofi’s counsel agreed could effectively wipe out patents involving genus claims if the Court sides with Sanofi, or—as counsel for Sanofi and the Solicitor General’s Office suggested the Court could do—if it were to dismiss the case as improvidently granted. [read post]
26 Mar 2023, 9:07 pm
Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure decisions, in this case enablement under 35 U.S.C. [read post]
